PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 24, 2026BMJ12 citationsOpen Access

Natural ovulation versus programmed regimens before frozen embryo transfer in ovulatory women: multicentre, randomised clinical trial

View Full Paper
DWDaimin WeiYQY QinYSYao Sun

Key Points

  • To compare the effectiveness of natural ovulation versus programmed regimens before frozen embryo transfer in increasing live birth rates and reducing maternal complications.
  • Conducted as a multicentre, randomised clinical trial across 24 fertility centres in China.
  • Involved 4376 ovulatory women aged 20-40 planning for frozen single blastocyst transfer.
  • Participants were randomized to either a natural ovulation regimen or a programmed hormone replacement regimen.
  • 41.6% in the natural regimen and 40.6% in the programmed group achieved a healthy live birth (P=0.49).
  • Natural regimen showed a lower risk of pre-eclampsia (2.9% vs. 4.6%, P=0.02).
  • Early pregnancy loss was 12.1% in the natural group versus 15.2% in the programmed group.
  • Lower rates of caesarean sections (69.5% vs. 75.6%) and postpartum haemorrhage (2.0% vs. 6.1%) were observed in the natural group.

Abstract

Abstract Objective To test the hypothesis that women assigned to a natural ovulation regimen before frozen embryo transfer compared with a programmed regimen would have an increased chance of a healthy live birth and a reduced risk of pre-eclampsia or eclampsia. Design Multicentre, randomised, parallel group, assessor blinded clinical trial. Setting 24 academic fertility centres in China. Participants 4376 ovulatory women (aged 20-40 years) planning to undergo a frozen single blastocyst transfer. Interventions Eligible participants were randomised (1:1) to receive a natural ovulation regimen or a programmed regimen of hormone replacement for endometrial preparation. Endometrial preparation and frozen embryo transfer timing were determined in the natural ovulation regimen group by monitoring natural follicle development and measuring serum levels of luteinising hormone, oestradiol, and progesterone. In the programmed regimen group, endometrial preparation was achieved by sequential administration of oestrogen and progesterone. Main outcomes and measures Primary outcomes were a healthy live birth and pre-eclampsia or eclampsia after a frozen embryo transfer. Secondary outcomes were cycle cancellation, biochemical pregnancy, clinical pregnancy, ongoing pregnancy, pregnancy loss, ectopic pregnancy, live birth, birth weight, and maternal, fetal, and neonatal complications. Results In the intention-to-treat analyses, 910 (41.6%) of 2185 patients in the natural ovulation regimen group and 890 (40.6%) of 2191 in the programmed regimen group achieved a healthy live birth (relative ratio 1.03 (95% confidence interval (CI) 0.96 to 1.10); P=0.49). The risk of pre-eclampsia was lower in the natural ovulation regimen group among patients who achieved clinical pregnancy than in the programmed regimen group (2.9% (38 of 1302) v 4.6% (61 of 1326); 0.63 (0.43 to 0.94); P=0.02). The incidences of early pregnancy loss (12.1% (158 of 1302) v 15.2% (201 of 1326); 0.80 (0.66 to 0.97)), placental accreta spectrum (1.8% (24 of 1302) v 3.6% (48 of 1326); 0.51 (0.31 to 0.83)), caesarean section (69.5% (776 of 1117) v 75.6% (831 of 1100); 0.92 (0.87 to 0.97)), and postpartum haemorrhage (2.0% (22 of 1117) v 6.1% (67 of 1100); 0.32 (0.20 to 0.52)) were lower in the natural ovulation regimen group. No differences between groups were observed for birth weight or neonatal complications. The rate of cycle cancellation was higher in the natural ovulation regimen (16.2% (354 of 2185) v 11.5% (251 of 2191), P<0.001). The prespecified per protocol and subgroup analyses yielded results consistent with the intention-to-treat analyses. Conclusions In ovulatory women, a natural ovulation regimen for endometrial preparation was as effective as programmed regimen in terms of achieving a healthy live birth after frozen embryo transfer, but with a lower risk of maternal complications during pregnancy. Trial registration Chinese Clinical Trial Registry ChiCTR2200057990.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wei et al. (2026) studied this question.

synapsesocial.com/papers/6974616cbb9d90c67120b406https://doi.org/10.1136/bmj-2025-087045
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association between being large for gestational age and cardiovascular metabolic health in children conceived from assisted reproductive technology: a prospective cohort study2024 · 3 citations
  2. 2Pre-eclampsia: pathophysiology and clinical implications2019 · 1,257 citations
  3. 3Gestational Hypertension and Preeclampsia2020 · 2,857 citations
  4. 4Comparison of clinical pregnancy rates between hormone replacement therapy and modified natural cycle for endometrial preparation in frozen embryo transfer cycles: An RCT2025 · 4 citations
  5. 5Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality2021 · 224 citations